Long-term haloperidol-treatment of mice: a change in beta-adrenergic receptor responsiveness
- PMID: 35585
- DOI: 10.1007/BF01253062
Long-term haloperidol-treatment of mice: a change in beta-adrenergic receptor responsiveness
Abstract
Mice administered haloperidol 3 mg/kg/day in their drinking water for 21 days were tested for their locomotor responsiveness to saline or acid vehicle, dl-, l- or d-propranolol, metoprolol, butoxamine or practolol. Haloperidol-treated animals administered saline or acid-vehicle were, in five of six experiments, more active than animals withdrawn from vehicle-treatment. Haloperidol- and vehicle-treated animals responded differently to the non-selective beta-adrenoreceptor antagonists (dl-propranolol and l-propranolol) and selective beta1-adrenoreceptor antagonists (practolol and metoprolol), but not to a selective beta2-adrenoreceptor antagonist (butoxamine). With dl-propranolol (4 mg/kg) the locomotor activity of haloperidol-treated animals was significantly (0.01 less than P less than 0.02) greater than that of the vehicle-treated animals. Similar effects in the same direction were seen with l-propranolol (1 mg/kg, 0.005 less than P less than 0.01), practolol (10 and 100 mg/kg, 0.025 less than P less than 0.05 and 0.01 less than P less than 0.025 respectively) and metoprolol 8 mg/kg, 0.005 less than P less than 0.01). The d-isomer of propranolol which is about 50 times less active as a beta-adrenoreceptor antagonist than the l-isomer, although having equal membrane stabilizing effects, did not differentially affect haloperidol- or vehicle-treated groups. The results suggest that there has been a change in beta 1-adrenoreceptor responsiveness in animals withdrawn from long-term haloperidol treatment.
Similar articles
-
Renal effects of propranolol, practolol and butoxamine in pentobarbital-anesthetized rats.Eur J Pharmacol. 1979 Jan 1;53(2):201-8. doi: 10.1016/0014-2999(79)90166-3. Eur J Pharmacol. 1979. PMID: 759198
-
Effects of beta adrenergic blocking agents on erythropoietin production in rabbits exposed to hypoxia.J Pharmacol Exp Ther. 1975 Apr;193(1):176-81. J Pharmacol Exp Ther. 1975. PMID: 237111
-
Mediation of isoproterenol-induced thirst in rats by beta2-adrenergic receptors.Can J Physiol Pharmacol. 1978 Jun;56(3):465-70. doi: 10.1139/y78-069. Can J Physiol Pharmacol. 1978. PMID: 208741
-
beta-Adrenoreceptor antagonists and the dysfunction of the blood-brain barrier induced by adrenaline.Brain Res. 1980 Jan 6;181(1):219-22. doi: 10.1016/0006-8993(80)91274-3. Brain Res. 1980. PMID: 6101306 No abstract available.
-
Effects of salbutamol and butoxamine on the human fat cell adenylate cyclase.Horm Metab Res. 1980 Dec;12(12):695-7. doi: 10.1055/s-2007-999234. Horm Metab Res. 1980. PMID: 6259042
Cited by
-
Chronic haloperidol and adrenergic receptor sensitivity in the rat.J Neural Transm. 1983;57(1-2):13-25. doi: 10.1007/BF01250044. J Neural Transm. 1983. PMID: 6619828
-
The effect of chronic haloperidol treatment on some cardiovascular parameters in cats.Br J Pharmacol. 1985 Nov;86(3):737-41. doi: 10.1111/j.1476-5381.1985.tb08953.x. Br J Pharmacol. 1985. PMID: 4063587 Free PMC article.
-
Changes of response to dopaminergic drugs in rats submitted to REM-sleep deprivation.Psychopharmacology (Berl). 1981;72(3):257-60. doi: 10.1007/BF00431826. Psychopharmacology (Berl). 1981. PMID: 6111823
-
Chronic treatment with chlorpromazine, thioridazine or haloperidol increases striatal enkephalins and their release from rat brain.Psychopharmacology (Berl). 1991;104(1):106-12. doi: 10.1007/BF02244563. Psychopharmacology (Berl). 1991. PMID: 1881995
-
Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia.Schizophr Bull. 2010 May;36(3):607-23. doi: 10.1093/schbul/sbn131. Epub 2008 Oct 8. Schizophr Bull. 2010. PMID: 18845557 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources